Castlight Health Inc (CSLT) EVP Sells $67,456.55 in Stock
Castlight Health Inc (NYSE:CSLT) EVP Neeraj Gupta sold 26,045 shares of Castlight Health stock in a transaction that occurred on Monday, November 19th. The stock was sold at an average price of $2.59, for a total transaction of $67,456.55. Following the completion of the transaction, the executive vice president now owns 253,169 shares in the company, valued at approximately $655,707.71. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink.
NYSE CSLT traded up $0.02 on Tuesday, hitting $2.75. 513,100 shares of the stock were exchanged, compared to its average volume of 553,196. Castlight Health Inc has a 52-week low of $2.20 and a 52-week high of $5.95. The company has a debt-to-equity ratio of 0.02, a quick ratio of 1.89 and a current ratio of 1.89. The stock has a market cap of $388.44 million, a price-to-earnings ratio of -10.58 and a beta of 1.09.
Castlight Health (NYSE:CSLT) last posted its quarterly earnings data on Tuesday, November 6th. The software maker reported ($0.01) earnings per share for the quarter, topping the consensus estimate of ($0.07) by $0.06. Castlight Health had a negative net margin of 29.23% and a negative return on equity of 16.59%. The firm had revenue of $40.04 million for the quarter, compared to analysts’ expectations of $38.11 million. During the same period in the previous year, the company posted ($0.05) EPS. The company’s quarterly revenue was up 16.1% compared to the same quarter last year. On average, research analysts forecast that Castlight Health Inc will post -0.23 EPS for the current fiscal year.
Several research firms have issued reports on CSLT. William Blair restated a “buy” rating on shares of Castlight Health in a research report on Thursday, October 18th. Zacks Investment Research upgraded shares of Castlight Health from a “hold” rating to a “strong-buy” rating and set a $3.25 price target on the stock in a research report on Friday, November 9th. ValuEngine lowered shares of Castlight Health from a “buy” rating to a “hold” rating in a research report on Monday, July 30th. Canaccord Genuity decreased their price target on shares of Castlight Health from $7.00 to $6.00 and set a “buy” rating on the stock in a research report on Tuesday, July 31st. Finally, Dougherty & Co decreased their price target on shares of Castlight Health from $6.00 to $5.00 and set a “buy” rating on the stock in a research report on Wednesday, October 31st. Two investment analysts have rated the stock with a hold rating, four have given a buy rating and one has given a strong buy rating to the company. The company has a consensus rating of “Buy” and an average target price of $4.81.
Castlight Health Company Profile
Castlight Health, Inc provides a software-as-a-service platform used for health benefits navigation for employees in the United States. Its platform matches employees to the resources their employers make available to them; managing a condition; and assists them to manage their benefits. The company also offers communication and testing, implementation, and user customer support services.
Recommended Story: Book Value Per Share in Stock Trading
Receive News & Ratings for Castlight Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Castlight Health and related companies with MarketBeat.com's FREE daily email newsletter.